Blood Levels of Some Toxic Metals and Their Potential Health Impact in Human Immunodeficiency Type 1 Infected Subjects.
Keywords:
Human immunodeficiency virus infection, toxic metals, oxidative stressAbstract
Background: The introduction of antiretroviral therapy in the management of immunodeficiency virus infection has reduced the mortality rate and increased the average life-expectancy of infected subjects. The prevalence of non-infectious chronic diseases and malignancies are also on the rise. Environmental pollutants could adversely impact on the prognostic outcomes of HIV-1 infection probably due to the combination of the effects of environmental exposures and chronic inflammation and the role of toxic metals exposure and their health impact in infected individuals have been under-reported.
Objective: To evaluate the levels of cadmium (Cd),lead (Pb), mercury (Hg) and nickel (Ni) in HIV-1 infected subjects on highly active anti-retroviral therapy(HAART), HAART-naïve and discusses their potential health impacts.
Materials and methods: The study participants were 300 made up of 100 confirmed HIV-1 positive on HAART, 100 HIV-1 positive HAART-naïve and 100 HIV-1 negative controls. Measured toxic metal levels were determined using inductively coupled plasma mass spectrometer (Agilent 7500, Norwalk, U.S.A)
Results: Data indicated significantly higher (p<0.001) measured toxic metals in HIV positive subjects than controls, with levels in subjects on HAART higher than HAART-naive.
Conclusion: High toxic metal levels may lead to increased oxidative stress and adverse prognostic outcomes. Periodic evaluation of toxic metals in HIV-1 infected subjects is suggested and preventive strategies of environmental pollutants should be adopted.
References
Centers for Disease Control and Prevention. IV surveillance—United States, 1981-2008. Morbid Mortal Weekly Report. 2011;60: 689-693.
Losina E, Freedberg KA (2011) Life expectancy in HIV. BMJ 343: doi:10.1136/bmj.d6015.
Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states,United States. J Acquir Immune DeficSyndr 2010;53:124-130.
Smith C, Sabin CA,Lundgren JD, Thiebaut R. DataCollectiononAdverseEventsof Anti HIVdSG. Factors associated with specific causes of death amongst HIV- positive individuals in the D:A:D Study. AIDS, 2010; 24: 1537-1548.
Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing and non- AIDS related morbidity. BMJ 2009;338: a3172.
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006;145: 397-406.
Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008;22: 2409-2418.
Akinola FF, Akinjinmi AA, Oguntibeju OO. Effect of combined Anti-retroviral Therapy on selected trace elements and CD4+ T-cells count in HIV positive persons in an African setting. AIDS Clinic Res 2012;3:10
Tellez-Plaza M, Guallar E, Howard BV, Umans JG, Francesconi KA, Goessler W et al. Cadmium exposure and incident of cardiovascular disease. Epidemiology 2013;24: 421-429.
Moon SS. Association of lead, mercury
and cadmium with diabetes in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Diabet Med 2013;30(4):e143-138.
Rhee SY, Hwang YC, Woo JT, Sinn DH, Chin SO, Chon S et al. Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008. Cardiovasc Diabetol 2013;12: 9. doi: 10.1186/1475-2840-12-9.
World Health Organization (WHO). Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach.2010 p. 108.
Hu H . Human Health and Heavy Metal Exposure. In: Life Support: Environ Human Health.2002;4:1–10.
Ivanov AV, Valnev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B. Oxidative stress during HIV infection: mechanism and consequences. Oxidative Med Cell Longevit 2016;89:1-18.
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Int Med 2006;145: 397-406.
Barbaro G, Klatt EC. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients. Curr Pharm Des 2003;9: 1475-1481.
Xu X, Hu H, Dailey AB, Kearney G, Talbott EO,Cook RL. Potential Health Impacts of Heavy Metals on HIV-Infected Population inUSA.PLoSONE 2013;8(9):e74288.
Fong BMW, Siu TS, Lee JSK,Tam S. Determination of Mercury in Whole Blood and Urine by Inductively Coupled Plasma Mass Spectrometry. J Analytic Toxicol 2007; 31: 281-287.
Chashchin VP, Frolova NM, Sologub TV,
Esadulenko EV. Influence of environmental and industrial immunotoxic hazards on clinical course of HIV-infection. Med Tr Prom Ekol 2010: 1-6.
Afridi HI, Kazi TG, Kazi N, Kandhro GA, Shah AQ, Baig JA et al. Evaluation of arsenic,cadmium, lead, nickel, and zinc in biological samples (scalp hair, blood, and urine) of tuberculosis and diarrhea male human imunodeficiency virus patients. Clin Lab 2011;57: 867-878.
Miro JM, Cofan F, Trullas JC, Manzardo C, Cervera C, Tuset M et al. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep 2012; 9:187-199.
Vallet-Pichard A, Mallet V, Pol S. Nonalcoholic fatty liver disease and HIV infection. Semin Liver Dis 2012; 32: 158- 166.
Jones M, Núñez M. Liver toxicity of antiretroviral drugs. Semin Liver Dis 2012; 32: 167-176.
Alissa EM, Ferns GA. Heavy metal poisoning and cardiovascular disease. J Toxicol 2011;2011:870125. doi: 10.1155/ 2011/870125.
Kim DS, Lee EH, Yu SD, Cha JH, Ahn SC. Heavy metal as risk factor of cardiovascular disease--an analysis of blood lead and urinary mercury. J Prev Med Public Health 2005;38: 401-407.
Chaisemartin RA, Chaisemartin C. Compared effects of heavy metal ions (Cr+IV and Pb2+)on the respiratory intensity of 2 Crustacea Decapoda Brachyoura: Macropodia rostrata and Pachygrapsus marmoratus. CR Seances Soc BiolFil1976;170:886-891.
Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, Pastor-Barriuso R.
Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect 2012; 120: 1017-1022.
Lee MS, Park SK, Hu H, Lee S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ Res 2011;111: 171-176.
Messner B, Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals 2010;23: 811- 822.
Ozturk IM, Buyukakilli B, Balli E, Cimen B, Gunes S, Erdogan S et al. Determination of acute and chronic effects of cadmium on the cardiovascular system of rats. Toxicol Mech Methods 2009;19: 308-317.
Stepanova NV.Immunity status of children under the conditions of heavy metal- polluted city. Gig Sanit: 2003; 42-44.
Pölkki M, Kangassalo K, Rantala MJ. Transgenerational effects of heavy metal pollution on immune defense of the blow fly Protophormia terraenovae. PLOS ONE 2012; 7: e38832.
Vigneshkumar B, Pandian SK, Balamurugan K, Catalase activity and innate immune response of Caenorhabditis elegans against the heavy metal toxin lead. Environ Toxicol 2011; 28: 313–21.
van Ooik T, Pausio S, Rantala MJ. Direct effects of heavy metal pollution on the immune function of a geometrid moth, Epirrita autumnata. Chemosphere 2008;71: 1840-1844.
Sorvari J, Rantala LM, Rantala MJ, Hakkarainen H, Eeva T.Heavy metal pollution disturbs immune response in wild ant populations. Environ Pollut 2007;145: 324-328.
Bouman A, Schipper M, Heineman MJ, Faas MM. Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immununol. 2004; 52: 19–26.
Deitch EA, Ananthakrishnan P, Cohen
DB, Xu DZ, Feketeova E, Hanser CJ. Neutrophil activation is modulated by sex hormones after trauma-hemorrhagic shock and burn injuries. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1456–H1465.
Emokpae MA, Mrakpor BA. Do sex differences in Respiratory Burst Enzyme activities exist in Human Immuno- deficiency virus-1 infection? Med Sci 2016;4:19 doi.10.3390.
Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock 2000, 14, 81–90.
Diodata MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response andsurvivalfollowing haemorrhageand subsequent sepsis. Cytokine 2001; 14:162–169.
Liochev SI, Hausladen A, Fridovich I. Nitroreductase A is regulated as a member of the soxRS regulon of Escherichia coli. Proc Natl Acad Sci (Bichem) 1999;96:3537-3539.
Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol Med 1995; 18: 321-336.
Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev. 1998 ;3(4):262-270.
Marth E, Jelovcan S, Kleinhappl B, Gutschi A,BarthS.Theeffectofheavy metalson the immune system at low concentrations. Int J Occup Med Environ Health 2001;14: 375-386.
Bal W, Kasprzak KS. Induction of oxidative DNA damage by carcinogenic metals. Toxicol Lett 2002;127(1-3):55-62.
Valko M, Morris H, Cronin MTD. Metals, Toxicity and Oxidative Stress. Curr Med Chem 2005; 12:1161–1208.
Anetor JI, Iyanda AA, Akinseye I, Anetor GO. Strengthening Analytical Capability in Micronutrients: A Prophylactic Approach to DNA Repair Defects, Genome Instability and Carcinogenesis in Developing Countries. Ann Biologic Tech 2013;17: 560–561.

Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
COPYRIGHT LICENSE
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0
International Public License
Section 1 -- Definitions.
a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
b. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
c. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
d. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
e. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
f. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
g. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
h. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.
i. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
j. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
k. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.
Section 2 -- Scope.
a. License grant.
- Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and
b. produce and reproduce, but not Share, Adapted Material for NonCommercial purposes only.
-
Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
-
Term. The term of this Public License is specified in Section 6(a).
-
Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
-
Downstream recipients.
a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
- No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).
b. Other rights.
-
Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
-
Patent and trademark rights are not licensed under this Public License.
-
To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.
Section 3 -- License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
a. Attribution.
- If You Share the Licensed Material, You must:
a. retain the following if it is supplied by the Licensor with the Licensed Material:
i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
ii. a copyright notice;
iii. a notice that refers to this Public License;
iv. a notice that refers to the disclaimer of warranties;
v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material.
-
You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
-
If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
Section 4 -- Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only and provided You do not Share Adapted Material;
b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.
Section 5 -- Disclaimer of Warranties and Limitation of Liability.
a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.
b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.
c. The disclaimer of warranties and
limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
Section 6 -- Term and Termination.
a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.
b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:
-
automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
-
upon express reinstatement by the Licensor.
For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.
Section 7 -- Other Terms and Conditions.
a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.
Section 8 -- Interpretation.
a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.